GLP-1 and GIP are hormones involved in blood sugar control and Mounjaro, a first-in-class medicine that activates both GLP-1 and GIP receptors, demonstrated improved blood sugar control
Presented for research literature review only Guo J et al
GLP-1 receptor agonist dosing varies significantly depending on the specific medication, indication (diabetes versus weight management), and formulation
[1] Speak to your prescriber if side effects are persistent, severe or concerning
No two patients are the same, which is why your treatment plan is built specifically for you
As estrogen fluctuates and declines, many women develop insulin resistancemeaning your cells dont respond as well to insulin, so your body produces more of it